Not sure where to start? Get matched →
All of Tesamorelin (Injectable)
Kentucky

Tesamorelin (Injectable) in Kentucky

Doctor-prescribed Tesamorelin (Injectable) for Kentucky residents. Reviewed by licensed Kentucky physicians, compounded at FDA-registered pharmacies, and shipped to your door.

All-in monthly price

$249

No membership fee · this is the full price · free shipping · avg 4-week supply

Medication, provider care, labs & dose adjustments — all in one price.
~28-day supply. Your provider sets your exact dose, so yours may vary — your refill arrives as you finish the last one.
Start assessment

Add in-depth bloodwork

Optional — add a physician-reviewed at-home blood panel to your plan.

At-home kit (1 device)+$149

Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.

Money-back guarantee
Free AI care assistant
HSA/FSA accepted
Cancel anytime
Free shipping

This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Dr. Gene
Physician Reviewed

Reviewed by Dr. Gene, MD · Board-certified Family Medicine

Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.

The process

How it works in Kentucky

  1. 1Complete a free online intake (~5 minutes).
  2. 2A licensed Kentucky physician reviews your case within 24 hours.
  3. 3Your prescription ships from our FDA-registered compounding pharmacy.
  4. 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
The treatment

What Tesamorelin (Injectable) does

FDA-studied growth hormone releasing factor analog that targets abdominal fat.

✓Visceral fat reduction
✓GH release
✓Cognitive function
✓Body composition
Formulation
Injectable vial5 mL · 2 mg/mL
Tesamorelin10 mg

Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.

Quality

Every batch independently tested

Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.

Sterility

USP <71>

Confirms the finished preparation is free of viable microorganisms.

Bacterial endotoxins

USP <85>

Screens for endotoxins that can cause fever or inflammatory reactions.

Potency

Assay

Verifies the labeled concentration of the active peptide is what is in the vial.

Purity

HPLC

Checks the active peptide against impurities and degradation products.

Identity

Mass spectrometry

Confirms the peptide in the vial is the correct molecule.

pH

USP <791>

Confirms the solution sits within the range specified for injection.

Particulate matter

USP <788>

Checks the finished vial for visible and sub-visible particles.

Container closure integrity

USP <1207>

Confirms the vial seal holds so sterility is maintained through the beyond-use date.

Recent lots

  • Lot 100526-TES-2

    Tested 2026-10-07 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    99.4%

  • Lot 100526-TES-4

    Tested 2026-10-07 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    100.4%

  • Lot 092826-TES-2

    Tested 2026-09-30 · Biolink Life Sciences Carolinas

    Sterility

    Sterile

    Endotoxin

    <2 EU/mL

    Potency

    99.7%

Compounded by licensed U.S. pharmacies. Prescribed by licensed medical providers. Shipped directly to patients in Kentucky.Documentation available upon request →View lab results by lot →
Kentucky

Telemedicine in Kentucky.

Kentucky permits telehealth prescribing under Kentucky Board of Medical Licensure telehealth rules. A Kentucky-licensed physician can establish the patient relationship through online intake review for non-controlled medications. Pepti is available in all 50 states and Washington, D.C.

Kentucky cities Pepti serves

Pepti delivers Tesamorelin (Injectable) to patients across Kentucky, including Louisville, Lexington, Bowling Green, Owensboro, Covington, Georgetown, Richmond, Elizabethtown, Florence, Nicholasville, Hopkinsville, Independence
+ 4 more cities, Jeffersontown, Frankfort, Henderson, Paducah
. All shipments use the same FDA-registered compounding pharmacy regardless of city.

Your protocol

How Tesamorelin is prescribed in Kentucky.

Who it's for

  • Adults with stubborn visceral (abdominal) fat
  • Patients pursuing body recomposition under physician supervision
  • People who want the strongest growth-hormone release this class of peptide offers

Your physician decides whether Tesamorelin is appropriate for you after reviewing your intake and labs.

Directions & duration

Inject 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime.

Cycle. Nightly, Monday through Friday, on an empty stomach. Ongoing monthly treatment; your physician adjusts the dose over time.
Ready for more? When you're ready for more, ask your physician to move you up to the next strength. Approved steps are charged at the price difference and applied to your next fill.
Directions shown are the pharmacy's standard for this preparation. Your prescription label is the final word.

What's included

  • Licensed physician review of your intake, history, and labs
  • Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
  • Every batch independently tested before release
  • Sterile syringes and alcohol prep pads for injectables
  • Tracked delivery to your door, refills on schedule
  • Message your physician anytime; dose changes without an appointment

Storage & handling

  • Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
  • One vial is your monthly supply. A fresh vial ships to your Kentucky address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
  • Protect from light. Wipe the stopper with an alcohol pad before every draw.
  • Dispose of syringes in the sharps container per the included instructions.

What to expect

A typical course of Tesamorelin in Kentucky.

TimeframeWhat patients commonly report
Weeks 1–3Many patients first notice deeper sleep, better recovery, and more daytime energy.
Weeks 4–8Changes around the midsection often become noticeable, especially with training and adequate protein. In its FDA trials tesamorelin reduced visceral fat over this timeframe.
Weeks 9–15 and onEffects tend to be cumulative and build with continued use. Your physician adjusts the dose over time.
Individual results vary. Compounded medications are not FDA-approved; a licensed physician determines whether treatment is appropriate and monitors your progress.

The science

How Tesamorelin works, and what the research shows.

How it works

Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction.

It's the only growth hormone releasing peptide with clinical trial data showing significant reduction in dangerous abdominal fat.

Clinical evidence

  • Tesamorelin has the strongest human evidence of any GHRH analog: it is FDA-approved (Egrifta) for excess abdominal fat in HIV-associated lipodystrophy, where phase 3 trials showed roughly 15–18% reductions in visceral adipose tissue over 26 weeks.

    Falutz et al., N Engl J Med 2007; and subsequent randomized trials
  • Use outside that indication — including general body-composition protocols — is off-label and decided by the prescribing physician.

Full references with PubMed links are listed further down the page.

References

  1. Falutz J, Allas S, Blot K et al.. Metabolic effects of a growth hormone-releasing factor in patients with HIV · N Engl J Med (2007) · PMID 18057338
  2. Stanley TL, Feldpausch MN, Oh J et al.. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial · JAMA (2014) · PMID 25038357
  3. Falutz J, Mamputu JC, Potvin D et al.. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data · J Clin Endocrinol Metab (2010) · PMID 20554713
  4. Falutz J, Potvin D, Mamputu JC et al.. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension · J Acquir Immune Defic Syndr (2010) · PMID 20101189
  5. Stanley TL, Fourman LT, Feldpausch MN et al.. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial · Lancet HIV (2019) · PMID 31611038
  6. Makimura H, Feldpausch MN, Rope AM et al.. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial · J Clin Endocrinol Metab (2012) · PMID 23015655
  7. Dal J, Leisner MZ, Hermansen K et al.. Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature · J Clin Endocrinol Metab (2018) · PMID 29590449
  8. Johannsson G, Touraine P, Feldt-Rasmussen U et al.. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients · J Clin Endocrinol Metab (2022) · PMID 35368070
  9. Zhou H, Sun L, Zhang S, Wang Y, Wang G. Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis · Pituitary (2021) · PMID 32888174
  10. Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly · Pituitary (2002) · PMID 12812310
  11. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays · Clinical Chemistry (2011) · PMID 21285256
  12. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B. Systematic review: the safety and efficacy of growth hormone in the healthy elderly · Annals of Internal Medicine (2007) · PMID 17227934
  13. Baker LD, Barsness SM, Borson S et al.. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial · Arch Neurol (2012) · PMID 22869065

Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

Pharmacy network accreditation

PCAB-accredited pharmacies on every order.

Every fulfillment runs through a PCAB-accredited pharmacy.

See the lab results
PCAB — Pharmacy Compounding Accreditation Board · Accredited
  • Rigorous third-party quality & safety inspections
  • Cleanliness and sterile processes
  • Proper ingredient sourcing
  • Accurate dosing and formulation
  • Staff training and procedures
  • Accredited by NABP & ACHC
Common questions

Frequently asked
about Tesamorelin (Injectable) in Kentucky.

Yes. Tesamorelin (Injectable) is legal when prescribed by a physician licensed in Kentucky and dispensed by an FDA-registered compounding pharmacy. Kentucky permits telehealth prescribing under Kentucky Board of Medical Licensure telehealth rules. A Kentucky-licensed physician can establish the patient relationship through online intake review for non-controlled medications.

33 more questions about Pepti, answered.

Pepti serves all of Kentucky. A physician licensed in Kentucky reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Kentucky street address. The price is the same as every other state.

Pepti operates in Kentucky through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.